BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27809455)

  • 1. Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma.
    Kim DS; Yu ES; Kang KW; Lee SR; Park Y; Sung HJ; Choi CW; Kim BS
    Korean J Intern Med; 2017 Jul; 32(4):711-721. PubMed ID: 27809455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma.
    Song GY; Jung SH; Kim K; Kim SJ; Yoon SE; Lee HS; Kim M; Ahn SY; Ahn JS; Yang DH; Kim HJ; Lee JJ
    BMC Cancer; 2020 Aug; 20(1):803. PubMed ID: 32831058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
    Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
    Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
    Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S
    World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma.
    Shi L; Qin X; Wang H; Xia Y; Li Y; Chen X; Shang L; Tai YT; Feng X; Acharya P; Acharya C; Xu Y; Deng S; Hao M; Zou D; Zhao Y; Ru K; Qiu L; An G
    Oncotarget; 2017 Mar; 8(12):18792-18801. PubMed ID: 27852046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea.
    Kim C; Lee HS; Min CK; Lee JJ; Kim K; Yoon DH; Eom HS; Lee H; Lee WS; Shin HJ; Lee JH; Park Y; Jo JC; Do YR; Mun YC
    Korean J Intern Med; 2015 Sep; 30(5):675-83. PubMed ID: 26354062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral Absolute Lymphocyte Count: An Economical and Clinical Available Immune-Related Prognostic Marker for Newly Diagnosed Multiple Myeloma.
    Yang Y; Liu Z; Wang H
    Med Sci Monit; 2020 Jul; 26():e923716. PubMed ID: 32732863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
    Zhang Y; Jiang C; Li J; Sun J; Qu X
    Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
    Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen.
    Jung SH; Kim JS; Lee WS; Oh SJ; Ahn JS; Yang DH; Kim YK; Kim HJ; Lee JJ
    Ann Hematol; 2016 Jan; 95(1):55-61. PubMed ID: 26467916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
    Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
    BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving borte- zomib-based therapy for multiple myeloma.
    Zhou X; Wang J; Xia J; Cheng F; Mao J; Zhu J; Guo H
    Cancer Biomark; 2018; 22(1):43-48. PubMed ID: 29562497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Inflammation Score in Surgical Patients with Colorectal Cancer.
    Seong MK
    J Korean Med Sci; 2015 Dec; 30(12):1793-9. PubMed ID: 26713054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance Of The Inflammatory Index-Based Scoring System In Patients Preliminarily Diagnosed With Multiple Myeloma In The Bortezomib-Based Chemotherapy Era.
    Liu S; Shi J; Guo H; Xu F; Wei M; Sun K; Chen Y
    Cancer Manag Res; 2019; 11():9409-9420. PubMed ID: 31807070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.
    Gondo T; Nakashima J; Ohno Y; Choichiro O; Horiguchi Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
    Urology; 2012 May; 79(5):1085-91. PubMed ID: 22446338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents.
    Romano A; Parrinello NL; Consoli ML; Marchionni L; Forte S; Conticello C; Pompa A; Corso A; Milone G; Di Raimondo F; Borrello I
    Ann Hematol; 2015 Nov; 94(11):1875-83. PubMed ID: 26223359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel immunological and nutritional-based prognostic index for gastric cancer.
    Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL
    World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Predictive Role of the Neutrophil/Lymphocyte Ratio in Survival with Multiple Myeloma: A Single Center Experience.
    Onec B; Okutan H; Albayrak M; Saribacak Can E; Aslan V; Unver Koluman B; Soyer Kosemehmetoglu O; Albayrak A; Kos DM
    J Clin Lab Anal; 2017 Mar; 31(2):. PubMed ID: 27500465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.